Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L Kaklamanis
Correlation of BRCA1, TXR1 and TSP1 mRNA Expression With Treatment Outcome to Docetaxel-Based First-Line Chemotherapy in Patients With Advanced/Metastatic Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine Plus Docetaxel in Non-Small-Cell Lung Cancer Patients
PLoS ONE
Multidisciplinary
Analysis of Continuous First‑line Treatment With Docetaxel and Carboplatin for Advanced Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Treatment Paradigms for Patients With Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-Line
Current Oncology
Oncology
Cost-Effectiveness of First-Line Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer Unsuitable for Chemotherapy
BMJ Open
Medicine
Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients
Korean Journal of Internal Medicine
Internal Medicine
Treatment Results Including More Than Third-Line Chemotherapy for Patients With Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
